Remicade vs. Apriso: side effect and effectiveness comparison - a phase IV clinical study
Summary:
We compare the side effects and drug effectiveness of Remicade and Apriso. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 299,925 people who take Remicade and Apriso, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
299,925 people who take Remicade and Apriso are studied.
What is Remicade?
Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 202,400 Remicade users for its effectiveness, alternative drugs and more.
What is Apriso?
Apriso has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 3,269 Apriso users for its effectiveness, alternative drugs and more.
Number of reports submitted per year:

Drugs being compared in this study:
- Apriso (mesalamine)
- Remicade (infliximab)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Remicade:
- not at all: 4.18 %
- somewhat: 15.21 %
- moderate: 28.04 %
- high: 33.37 %
- very high: 19.2 %
Apriso:
- not at all: 3.51 %
- somewhat: 19.66 %
- moderate: 32.71 %
- high: 29.69 %
- very high: 14.44 %
Want to compare Remicade with Apriso?
Personalize this study to your gender and age (0-99+).How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
Related studies
Alternative drugs to, pros and cons of:
Common Remicade side effects:
- Drug ineffective: 37,128 reports
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints): 19,890 reports
- Pain: 15,675 reports
- Rashes (redness): 13,566 reports
- Joint pain: 13,157 reports
- Fatigue (feeling of tiredness): 12,449 reports
Browse all side effects of Remicade:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Apriso side effects:
- Diarrhea: 318 reports
- Drug ineffective: 284 reports
- Ulcerative colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 236 reports
- Fatigue (feeling of tiredness): 203 reports
- Crohn's disease (condition that causes inflammation of the gastrointestinal tract): 159 reports
- Joint pain: 150 reports
- Abdominal pain: 144 reports
Browse all side effects of Apriso:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on infliximab and mesalamine (the active ingredients of Remicade and Apriso, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Garlic Oil and Imbruvica drug interaction - 10 seconds ago
- Advil Pm and Excedrin drug interaction - 11 seconds ago
- Kombiglyze Xr and Visual Impairment - 16 seconds ago
- Slynd and Dermatitis Atopic Aggravated - 21 seconds ago
- Sarafem and Rheumatoid Arthritis - 28 seconds ago
- Saw Palmetto and Morphine drug interaction - 39 seconds ago
- Xolair and Lovaza drug interaction - 43 seconds ago
- Lomotil and Celebrex drug interaction - 46 seconds ago
- Methylprednisolone Acetate and Abscess - 54 seconds ago
- Tolterodine Tartrate and Timolol Maleate drug interaction - a minute ago